Aglaia Schiza

Immune checkpoint inhibitor treatment: real-world use and outcomes in Sweden 2015-2023

Illergard, Kristoffer; Soto, Pablo; Arpegård, Johannes; Schiza, Aglaia et al.

Ingår i Upsala Journal of Medical Sciences, 2026

• DOI för Immune checkpoint inhibitor treatment: real-world use and outcomes in Sweden 2015-2023
• Ladda ner fulltext (pdf) av Immune checkpoint inhibitor treatment: real-world use and outcomes in Sweden 2015-2023

CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study

Schiza, Aglaia; Fountzilas, E.; Biganzoli, Laura; Digkas, Evangelos et al.

Ingår i Journal of Geriatric Oncology, 2026

• DOI för CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study
• Ladda ner fulltext (pdf) av CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study

Endocrine therapy and COVID-19 outcomes in women with breast cancer: a nationwide register-based matched cohort study

Schiza, Aglaia; Digkas, Evangelos; Papadopoulos, Fotios; Skalkidou, Alkistis et al.

Ingår i BMC Cancer, 2026

• DOI för Endocrine therapy and COVID-19 outcomes in women with breast cancer: a nationwide register-based matched cohort study
• Ladda ner fulltext (pdf) av Endocrine therapy and COVID-19 outcomes in women with breast cancer: a nationwide register-based matched cohort study

Prognosis of Metaplastic Breast Cancer: A Population-Based Matched Cohort Study

Bergman, Marie; Schiza, Aglaia; Boyaci, Ceren; Acs, Balazs et al.

Ingår i Cancer Medicine, 2026

• DOI för Prognosis of Metaplastic Breast Cancer: A Population-Based Matched Cohort Study
• Ladda ner fulltext (pdf) av Prognosis of Metaplastic Breast Cancer: A Population-Based Matched Cohort Study

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE

Matikas, Alexios; Naume, Bjorn; Wildiers, Hans; Sonke, Gabe et al.

Ingår i BMJ Open, 2025

• DOI för Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE
• Ladda ner fulltext (pdf) av Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE

Immune checkpoint inhibitor treatment: real-world use and outcomes in Sweden 2015-2023

Illergard, Kristoffer; Soto, Pablo; Arpegård, Johannes; Schiza, Aglaia et al.

Ingår i Upsala Journal of Medical Sciences, 2026

• DOI för Immune checkpoint inhibitor treatment: real-world use and outcomes in Sweden 2015-2023
• Ladda ner fulltext (pdf) av Immune checkpoint inhibitor treatment: real-world use and outcomes in Sweden 2015-2023

CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study

Schiza, Aglaia; Fountzilas, E.; Biganzoli, Laura; Digkas, Evangelos et al.

Ingår i Journal of Geriatric Oncology, 2026

• DOI för CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study
• Ladda ner fulltext (pdf) av CDK4/6 inhibitor dose patterns among older patients with metastatic breast cancer: A multinational survey study

Endocrine therapy and COVID-19 outcomes in women with breast cancer: a nationwide register-based matched cohort study

Schiza, Aglaia; Digkas, Evangelos; Papadopoulos, Fotios; Skalkidou, Alkistis et al.

Ingår i BMC Cancer, 2026

• DOI för Endocrine therapy and COVID-19 outcomes in women with breast cancer: a nationwide register-based matched cohort study
• Ladda ner fulltext (pdf) av Endocrine therapy and COVID-19 outcomes in women with breast cancer: a nationwide register-based matched cohort study

Prognosis of Metaplastic Breast Cancer: A Population-Based Matched Cohort Study

Bergman, Marie; Schiza, Aglaia; Boyaci, Ceren; Acs, Balazs et al.

Ingår i Cancer Medicine, 2026

• DOI för Prognosis of Metaplastic Breast Cancer: A Population-Based Matched Cohort Study
• Ladda ner fulltext (pdf) av Prognosis of Metaplastic Breast Cancer: A Population-Based Matched Cohort Study

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE

Matikas, Alexios; Naume, Bjorn; Wildiers, Hans; Sonke, Gabe et al.

Ingår i BMJ Open, 2025

• DOI för Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE
• Ladda ner fulltext (pdf) av Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

He, Liqun; Testini, Chiara; Hekmati, Neda; Bonello, Altea et al.

Ingår i Molecular Oncology, 2025

• DOI för Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity
• Ladda ner fulltext (pdf) av Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial

Lopez, Juanita; Powles, Thomas; Braiteh, Fadi; Siu, Lillian L. et al.

Ingår i Nature Medicine, s. 152-164, 2025

• DOI för Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
• Ladda ner fulltext (pdf) av Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial

Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients

Valachis, Antonis; Biganzoli, Laura; Christopoulou, Athina; Fjermeros, Kamilla et al.

Ingår i Future Oncology, s. 2937-2948, 2024

• DOI för Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients
• Ladda ner fulltext (pdf) av Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients

Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study

Strell, Carina; Smith, Daniel Robert; Valachis, Antonis; Woldeyesus, Hellen et al.

Ingår i Breast Cancer Research and Treatment, s. 293-299, 2024

• DOI för Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study
• Ladda ner fulltext (pdf) av Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study

Effect of mode of delivery of patient reported outcomes in patients with breast disease: a randomised controlled trial

Pantiora, Eirini; Hedman, Lia-Chasmine; Aristokleous, Iliana; Sjökvist, Olivia et al.

Ingår i International Journal of Surgery, s. 176-182, 2024

• DOI för Effect of mode of delivery of patient reported outcomes in patients with breast disease: a randomised controlled trial
• Ladda ner fulltext (pdf) av Effect of mode of delivery of patient reported outcomes in patients with breast disease: a randomised controlled trial

Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study

Schiza, Aglaia; Fredriksson, Irma; Sund, Malin; Valachis, Antonios

Ingår i Breast Cancer Research and Treatment, s. 235-243, 2024

• DOI för Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study
• Ladda ner fulltext (pdf) av Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study

De novo metastatic breast cancer in men vs women: a Swedish population-based cohort study

Schiza, Aglaia; Fredriksson, Irma; Sund, Malin; Valachis, Antonis

Ingår i JNCI Cancer Spectrum, 2023

• DOI för De novo metastatic breast cancer in men vs women: a Swedish population-based cohort study
• Ladda ner fulltext (pdf) av De novo metastatic breast cancer in men vs women: a Swedish population-based cohort study

Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial

Schiza, Aglaia; Thurfjell, Viktoria; Stenmark Tullberg, Axel; Olofsson, Helena et al.

Ingår i European Journal of Cancer, s. 128-137, 2022

• DOI för Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial
• Ladda ner fulltext (pdf) av Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial

A case report of a patient with metastatic uveal melanoma who experienced a complete response to treatment with the NIVO3+IPI1 regimen

Schiza, Aglaia; Naeser, Ylva; Sundin, Anders; Ullenhag, Gustav

Ingår i Clinical Oncology: Case Reports, 2021

Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial

Hatschek, Thomas; Foukakis, Theodoros; Bjohle, Judith; Lekberg, Tobias et al.

Ingår i JAMA Oncology, s. 1360, 2021

• DOI för Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial

Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort study

Schiza, Aglaia; Mauri, Davide; Fredriksson, Irma; Wennstig, Anna-Karin et al.

Ingår i Breast Cancer Research and Treatment, s. 779-789, 2021

• DOI för Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort study
• Ladda ner fulltext (pdf) av Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort study

High PDGFRb Expression Predicts Resistance to Radiotherapy in DCIS within the SweDCIS Randomized Trial

Strell, Carina; Folkvaljon, Dick; Holmberg, Erik; Schiza, Aglaia et al.

Ingår i Clinical Cancer Research, s. 3469-3477, 2021

• DOI för High PDGFRb Expression Predicts Resistance to Radiotherapy in DCIS within the SweDCIS Randomized Trial

Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

Schiza, Aglaia; Irenaeus, Sandra; Ortiz-Nieto, Francisco; Loskog, Angelica S. et al.

Ingår i Scientific Reports, 2019

• DOI för Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients
• Ladda ner fulltext (pdf) av Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

Evidence on the occurrence of brain metastases amongst deceased metastatic breast cancer patients from an Uppsala county disease registry

Lindman, Henrik; Haji, A.; Jernling, M.; Schiza, Aglaia

Ingår i European Journal of Cancer, 2018

Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients

Schiza, Aglaia; Wenthe, Jessica; Mangsbo, Sara; Svensson, Emma et al.

Ingår i Journal of Translational Medicine, 2017

• DOI för Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
• Ladda ner fulltext (pdf) av Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients

Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients

Irenaeus, Sandra; Schiza, Aglaia; Mangsbo, Sara M.; Wenthe, Jessica et al.

Ingår i Oncotarget, s. 78573-78587, 2017

• DOI för Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients
• Ladda ner fulltext (pdf) av Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients

Adenovirus-mediated CD40L gene transfer increases teffector/tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients

Schiza, Aglaia; Wenthe, Jessica; Mangsbo, Sara; Eriksson, Emma et al.

Ingår i Scandinavian Journal of Immunology, s. 337-337, 2017

A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib

Maleka, Aglaia; Åström, Gunnar; Bystrom, P.; Ullenhag, Gustav J.

Ingår i BMC Cancer, 2016

• DOI för A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib
• Ladda ner fulltext (pdf) av A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib

Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients

Loskog, Angelica; Maleka, Aglaia; Mangsbo, Sara; Svensson, Emma et al.

Ingår i British Journal of Cancer, s. 872-880, 2016

• DOI för Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients

AdCD40L Immunostimulatory Gene Therapy in Combination with Cyclophosphamide Prolongs 6-Months Survival in a Phase I/II Trial for Malignant Melanoma

Loskog, Angelica; Maleka, Aglaia; Mangsbo, Sara; Svensson, Emma et al.

Ingår i Molecular Therapy, 2014

• DOI för AdCD40L Immunostimulatory Gene Therapy in Combination with Cyclophosphamide Prolongs 6-Months Survival in a Phase I/II Trial for Malignant Melanoma

Treatment of metastatic malignant melanoma with vemurafenib during pregnancy

Maleka, Aglaia; Enblad, Gunilla; Sjörs, Gunnar; Lindqvist, Anna et al.

Ingår i Journal of Clinical Oncology, 2013

• DOI för Treatment of metastatic malignant melanoma with vemurafenib during pregnancy
• Ladda ner fulltext (pdf) av Treatment of metastatic malignant melanoma with vemurafenib during pregnancy

Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis

Fountoukidis, Georgios; Schiza, Aglaia; Smith, Daniel; Othman, Mukhrizah et al.

Ingår i BMC Cancer, 2025

• DOI för Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis
• Ladda ner fulltext (pdf) av Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis

Clinical trials in older patients with cancer - typical challenges, possible solutions, and a paradigm of study design in breast cancer

Karihtala, Peeter; Schiza, Aglaia; Fountzilas, Elena; Geisler, Jürgen et al.

Ingår i Acta Oncologica, s. 441-447, 2024

• DOI för Clinical trials in older patients with cancer - typical challenges, possible solutions, and a paradigm of study design in breast cancer
• Ladda ner fulltext (pdf) av Clinical trials in older patients with cancer - typical challenges, possible solutions, and a paradigm of study design in breast cancer

Experimental treatment of patients with disseminated malignant melanoma

Schiza, Aglaia

2017

• Ladda ner fulltext (pdf) av Experimental treatment of patients with disseminated malignant melanoma

Metastatic breast cancer: diagnosis and oncological management

Schiza, Aglaia; Lindman, Henrik

Ingår i Breast cancer management for surgeons, s. 357-383, Springer, 2023

• DOI för Metastatic breast cancer: diagnosis and oncological management

AdCD40L Immunstimulatory Gene Therapy in Combination with Cyclophosphamide Prolongs 6-Months Survival in a Phase I/II Trial for Malignant Melanoma.

Maleka, Aglaia

2014

Diffusion-Weighted MRI may be better than FDG-PET/CT to assess immunotherapy response in patients with metastatic melanoma

Schiza, Aglaia; Irenaeus, Sandra; Ortiz-Nieto, Francisco; Loskog, Angelica et al.

Safety of intratumoral immunostimulatory LOAd703 gene therapy in patients with advanced cancer

Irenaeus, Sandra; Wenthe, Jessica; Eriksson, Emma; Schiza, Aglaia et al.

Biopsy-to-Surgery TIL Dynamics Reveal Persistent Immune Infiltration in Residual Triple-Negative Breast Cancer

Thurfjell, Viktoria; Lessan-Toussi, Ghazal; Hekmati, Neda; Micke, Patrick et al.